PubMed:12379519 / 1148-2159 JSONTXT

Annnotations TAB JSON ListView MergeView

DisGeNET

Id Subject Object Predicate Lexical cue
T0 490-495 gene:4312 denotes MMP-1
T1 472-474 disease:C0029408 denotes OA
R1 T0 T1 associated_with MMP-1,OA

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
12379519-11#34#39#gene4312 490-495 gene4312 denotes MMP-1
12379519-11#16#18#diseaseC0029408 472-474 diseaseC0029408 denotes OA
12379519-12#68#73#gene4312 784-789 gene4312 denotes MMP-1
12379519-12#78#83#gene4318 794-799 gene4318 denotes MMP-9
12379519-12#102#104#diseaseC0003873 818-820 diseaseC0003873 denotes RA
34#39#gene431216#18#diseaseC0029408 12379519-11#34#39#gene4312 12379519-11#16#18#diseaseC0029408 associated_with MMP-1,OA
68#73#gene4312102#104#diseaseC0003873 12379519-12#68#73#gene4312 12379519-12#102#104#diseaseC0003873 associated_with MMP-1,RA
78#83#gene4318102#104#diseaseC0003873 12379519-12#78#83#gene4318 12379519-12#102#104#diseaseC0003873 associated_with MMP-9,RA

PubMed_Structured_Abstracts

Id Subject Object Predicate Lexical cue
T4 0-1011 RESULTS denotes FLS from RA showed greater invasive growth than FLS from OA and AVN. The median number of cells that grew through the matrix membrane was 4788 for RA, significantly higher than the number for OA, 1875 (p<0.001) and for AVN, 1530 (p=0.014). The median rate of proliferation of RA FLS was 0.27 per day compared with OA 0.22 per day (p= 0.012) and AVN 0.25 per day, but there was no correlation between the rate of proliferation and invasive growth in vitro. FLS from RA and OA that expressed MMP-1, MMP-3, or MMP-10 were significantly more invasive (median number of invasive cells: 3835, 4248, 4990, respectively) than cells that did not express these MMPs (1605, p=0.03; 1970, p=0.004; 2360, p=0.012, respectively). There was also a significant relationship between the expression of MMP-1 and MMP-9 and the diagnosis RA (both p=0.013). The expression levels of mRNA for MMP-1 and MMP-2 correlated with the protein levels produced by the synoviocytes as measured by an enzyme linked immunosorbent assay (ELISA).